Henrik Endeman Selected Research

Henrik Endeman Research Topics

Disease

16	Critical Illness (Critically Ill) 07/2022 - 01/2011
14	Pneumonia (Pneumonitis) 01/2022 - 01/2007
10	Infections 07/2022 - 01/2011
9	Inflammation (Inflammations) 02/2022 - 01/2011
8	COVID-19 02/2022 - 01/2021
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 09/2015
3	Sepsis (Septicemia) 01/2021 - 07/2016
3	Heart Arrest (Cardiac Arrest) 01/2020 - 01/2015
2	Thrombosis (Thrombus) 01/2022 - 01/2021
2	Pneumococcal Infections 01/2022 - 04/2008
2	Septic Shock (Toxic Shock Syndrome) 01/2021 - 07/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2011
2	Hypoxia (Hypoxemia) 01/2021 - 05/2018
2	Pneumothorax 05/2018 - 09/2015
2	Pulmonary Atelectasis 05/2018 - 09/2015
2	Pneumococcal Pneumonia 11/2014 - 01/2013
1	Delirium 02/2022
1	Coinfection 02/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Acute Coronary Syndrome 10/2020
1	Cardiogenic Shock 10/2020
1	Hemorrhage 01/2020
1	Cytokine Release Syndrome 01/2020
1	Pain (Aches) 01/2019
1	Bacterial Infections (Bacterial Infection) 07/2016
1	Bacteremia 09/2011
1	Peritonitis 03/2011
1	Shock 01/2011

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2008
4	beta-LactamsIBA 07/2022 - 04/2008
4	AntibodiesIBA 01/2022 - 05/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
3	C-Reactive ProteinIBA 02/2022 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2017 - 12/2008
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2011 - 01/2007
2	ProcalcitoninIBA 02/2022 - 07/2016
2	beta Lactam AntibioticsIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
2	Viral RNAIBA 11/2021 - 01/2021
2	CytokinesIBA 01/2021 - 01/2020
2	ChemokinesIBA 01/2021 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2012 - 06/2011
1	Haloperidol (Haldol)FDA LinkGeneric 02/2022
1	fibrin fragment D (D-dimer)IBA 02/2022
1	SteroidsIBA 01/2022
1	FibrinIBA 01/2022
1	BenzodiazepinesIBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	LactamsIBA 04/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Antinuclear AntibodiesIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	CoagulaseIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2021
1	Endothelin A ReceptorIBA 01/2021
1	Type 1 Angiotensin ReceptorIBA 01/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	FicolinsIBA 01/2017
1	Granzymes (Granzyme)IBA 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2015
1	Expectorants (Mucolytics)IBA 09/2015
1	Albuterol (Salbutamol)FDA LinkGeneric 09/2015
1	ManganeseIBA 11/2014
1	ZincIBA 11/2014
1	lipoteichoic acidIBA 11/2014
1	AntigensIBA 01/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2012
1	Indicators and Reagents (Reagents)IBA 09/2011
1	Amino Acids FDA Link 03/2011
1	Complement System Proteins (Complement)IBA 03/2011
1	LectinsIBA 03/2011
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2011
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2011
1	Colistin (Coly-Mycin)FDA Link 01/2011

Therapy/Procedure

7	Therapeutics 04/2021 - 01/2008
6	Length of Stay 01/2022 - 01/2008
2	Cardiopulmonary Resuscitation (CPR) 01/2020 - 10/2019
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2020 - 05/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2020
1	Continuous Renal Replacement Therapy 01/2021
1	Counterpulsation (External Counterpulsation) 10/2020
1	Heart-Assist Devices 10/2020
1	Resuscitation 01/2020
1	Critical Care (Surgical Intensive Care) 01/2019
1	Duration of Therapy 07/2016
1	Induced Hypothermia 01/2015
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 03/2011
1	Peritoneal Dialysis 03/2011